Meningitis vaccine approved for California college

Health officials at a Southern California college will start offering a vaccine against bacterial meningitis after an outbreak in November.

Officials at the University of California, Santa Barbara said Friday that federal health regulators have approved the vaccine for use on campus. The vaccine is approved for use overseas but is not yet approved for general use in the United States.

The move comes after Princeton University last year received permission to dole out the after eight students became infected.

Four students at Santa Barbara fell ill in November. Three recovered and the fourth had both feet amputated. No new cases have been diagnosed.

Meningococcal disease can be spread among people in dormitories and other crowded settings.

The university plans to hold a two-week vaccination clinic in late February.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Princeton vaccine reaches 90 percent of eligible

Dec 13, 2013

Princeton University officials say more than 90 percent of the eligible students and staff received a meningitis vaccine this week as part of the university's effort to halt an outbreak.

Recommended for you

Mirabegron for overactive bladder: Added benefit not proven

9 hours ago

Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products ...

Novartis Japan admits concealing drug side effects

Sep 01, 2014

The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.

Most US babies get their vaccines, CDC says

Aug 28, 2014

(HealthDay)—The vast majority of American babies are getting the vaccines they need to protect them from serious illnesses, federal health officials said Thursday.

User comments